Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NIH

Biosafety legislation gets politicized

COVID-19 has polarized conversations about lab safety. Pushes for more oversight are increasingly from Republicans

Salon

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

How will Fauci be remembered by history?

The chief medical advisor became a household name during the COVID years, while being vilified by many on the right

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Fauci to step down in December after decades of public service

Dr. Anthony Fauci helped guide the U.S. through the COVID crisis, and earlier in his career played a key role in the response to AIDS. He has served under seven presidents.

WEKU

Fauci to step down in December - Roll Call

Fauci will step down after more than 50 years of government service where he helped respond to HIV/AIDS, Zika, Ebola and COVID-19.

Roll Call

Feds To Identify Marijuana Research Obstacles, Ontario Cannabis Shop Recovers From Cyberattack & More Industry Updates

Ontario Cannabis Store To Resume Deliveries After Cyberattack

Benzinga

Cannabis' Medicinal Properties And Lower Covid Hospitalizations: Is There A Connection? Here's What A New Study Found

A new study found that "cannabis consumption is associated with lower COVID-19 severity among hospitalized patients."

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Ashton Kutcher says he was lucky to survive a rare form of the disease vasculitis

The actor said he suffered from hearing, vision and balance issues and that it took him an entire year to recover from the autoimmune condition that causes the swelling of blood vessels.

WEKU

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary

Avalo Therapeutics (NASDAQ:AVTX) has dosed the first patient in the pivotal LADDER trial to assess the efficacy and safety of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II (LAD II) ER). Avalo shares traded in a range of $3.5 to $3.91 on a day volume of 33.54 thousand shares,…

Benzinga

Lobbying ramps up around new health agency headquarters - Roll Call

At least 10 states have expressed interest in hosting the new agency, tasked with speeding to market innovative health technologies.

Roll Call

Psychedelics And The National Institutes Of Health—How Do They Relate?

As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedel

Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga

Johns Hopkins University can continue barn owl testing after permit battle with PETA

BALTIMORE — A Johns Hopkins University researcher can continue medical experiments on barn owls after a lengthy battle with the People for the Ethical Treatment of Animals over animal cruelty and permit complaints.

Tribune News Service

Long Covid: what we know about it and how best to treat it

Symptoms can persist for weeks but work on causes and treatments is still developing. Here’s what we know so far

The Guardian - AU

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Biomedical grantmakers' diversity push gains new momentum

The Howard Hughes Medical Institute, one of the nation’s wealthiest philanthropies, announced a $1.5 billion effort designed to help scientists of color advance in their careers

Benzinga

Indiana University Neuroscientists Receive $2M To Conduct Study On Impact Of Cannabis Use During Adolescence

Recently, Neuroscientists from the Indiana University (IU) Gill Center for Biomolecular Science received more than $2 million from the NIH's National Institute on Drug Abuse&nbs

Benzinga

Federal Health Officials' Letter To Senators: Psychedelics Illegal Status Limits Research

As reported by Marijuana Moment, officials of the U.S. National Institutes of Health (NIH) replied to two senators’ request for a psychedelics research update with a letter stating that federal prohibit

Inverse

Male birth control is at our fingertips. Will we ever grasp it?

The research behind hormonal male birth control is about as old as the pill. But a safe and effective candidate is tantalizingly close to market.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Efficacy Of Pfizer's Paxlovid COVID Drug Crashes, According To New NIH-Funded Study

A new National Institutes of Health (NIH) funded study sheds new light on the waning effectiveness of Pfizer’s (NYSE: PFE) Paxlovid to prevent patient hospitalizations due to COVID.

Reuters

Pakistan orders masks on domestic flights as COVID numbers rise

Pakistan’s aviation regulator has made masks mandatory on domestic flights given a gradual rise in the number of COVID-19 cases across the country, it said a statement.

Benzinga

MNOV: Positive Results for MN-166 (Ibudilast) in Patients at Risk of Acute Respiratory Distress Syndrome…

By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT

Al Jazeera

Dr Fauci, renowned pandemic adviser, tests positive for COVID

Dr Fauci became a household name for his reassuring and professional presence early in the pandemic.

The Independent UK

Anthony Fauci on the Aids crisis, monkeypox, trans rights and his retirement

In an exclusive interview with Io Dodds, Dr Anthony Fauci looks back on his decades-long career in public health

Tribune News Service

Dr. Fauci tests positive for COVID

Dr. Anthony Fauci tested positive for COVID on Wednesday morning.

The Guardian - US

Anthony Fauci tests positive for Covid with mild symptoms

Biden’s chief medical adviser received two booster shots and is working from home, says National Institutes of Health

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.